CURRICULUM VITAE
GABRIEL, Victor Né le 27 novembre 1951 à Luanda (Angola), Nationalité Suisse Marié, 3 enfants (1969, 1983, 1993) Langue maternelle : Français et Portugais Autres langues : anglais, espagnol, italien et lingala Hobby : Windsurf |
![]() |
||
![]() |
Adresses Email : victor.gabriel@abc.ch |
|
![]() |
||
Actuellement
Consultant en informatique |
||
![]() |
||
Activités professionnelles
1998 – 2006 1996 – 1998 1988 – 1998 1975 – 1988 1974 - 1975 1971 - 1974 |
||
![]() |
||
Expériences professionnelles
2007 1998 – 2006 2006 2005 2005 2004 2004 2003 2003 2003 1999 1999 1996 - 1998 1997 - 1998 1997 1997 1997 1997 1997 1997 1996 1996 - 1998 1996 1996 - 1997 1996 - 1997 1995 1995 1993 1992 1998 1988 - 1998 1980 - 1988 1981 - 1983 1980 - 1981 1975 - 1988 |
||
![]() |
||
Formation
2004 1999 1998 1991 1978 1976 1973 1967-1968 1957-1967 1969-1970 |
||
![]() |
||
Participation aux publications scientifiques suivantes
Effects of a structured patient-centered discharge interview on patients' knowledge about their medications. Cefepime--assessment of its need at a tertiary care center. Cytomegalovirus retinitis: decreased risk of bilaterality with increased use
of systemic treatment. ddI + d4T +/- hydroxyurea in moderately immunosuppressed HIV-1 infected
patients. Treatment of advanced HIV infection with ritonavir plus saquinavir. Adding saquinavir to d4T in advanced HIV-1 infection. Cytomegalovirus retinitis: decreased risk of bilateralisation with more
systemic treatment. Switch or add: a randomised trial of AZT/ddI combination vs ddI alone among
patients pre-treated with AZT. Reasons for failure or prevention of Toxoplasma Encephalitis. Reasons for failure of prevention of Toxoplasma encephalitis. Long-term visual outcome in CMV retinitis. Slow-down of HIV epidemic among IDUs in Geneva, Switzerland. Relapse of HIV-related thrombocytopenia (HIV-TCP) after switching from
zidovudine (zdv) to didanosine (ddI). High and increasing incidence of M. avium-intracellulare infections. (MAI).
The Swiss Cohort Study. Compliance of drug users with zidovudine treatment. The efficacy of pneumococcal vaccination in HIV seropositive patients (HIV+):
a case-control study. Toxoplasma encephalitis in AIDS. Maintenance treatment after cerebral toxoplasmosis (TOXO) protects against
Pneumocystis pneumonia (PCP). Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii
pneumonia in patients with AIDS. The Swiss
HIV Cohort Study. Care of AIDS patients in Geneva, 1981-1989. No correlation between hepatitis C virus (HCV) and HIV-1 infections in I.V.
drug users (IVDUs). A controlled study of early neurologic abnormalities in asymptomatic
HIV-infected homosexual men. Loss of antibodies against hepatitis C virus in HIV-seropositive intravenous
drug users. Behavioral changes in intravenous drug users in Geneva: rise and fall of HIV
infection |
||
![]() |
||
Participation active aux publications scientifiques suivantes
Risk factors for tuberculosis among HIV-infected patients in Switzerland : A
case-control study. Dapsone/pyrimethamine may prevent mycobacterial disease in immunosuppressend
patients infected with the human immunodeficiency virus. Once weekly administration of dapsone-pyrimethamine vs. aerosolized
pentamidine as combined prophylaxis for Pneumcystis carinii pneumonia and
toxoplasma encephalitis in HIV-infected patients. Clinical and epidemiologic features of infection with Mycobacterium
genavense. Response of HIV RNA to didanosine as a predictive marker of survival. Zidovudine versus placebo in primary HIV infection: A randomized study. A cohort study of drug users' compliance with zidovudine treatment. Aspect et fréquence des précipités rétrocornéens lors du diagnostic de
la rétinite à CMV chez le patient VIH+. Le déclin d'une épidémie: Le VIH parmi les toxicomanes à Genève,
1988-1994. Infections with hepatitis B, hepatitis C, and HIV in a cohort of drug users. Soins hospitaliers pour les patients présentant un SIDA. Différences avec
les autres patients hospitalisés. A controlled study of inhaled pentamidine for primary prevention of
Pneumocystis carinii pneumonia (PCP). Primary prevention of pneumocystis carinii pneumonia by inhalation of
pentamidine: preliminary results from a placebo-controlled randomized trial. |
||
![]() |
dernière mise à jour
29/01/2008